Jupiter Neurosciences (JUNS) Stock Price
Jupiter Neurosciences Price
Revenue at Jupiter Neurosciences has contracted by 54.6% per year over the past 5 years to 21,796.00 USD. For Jupiter Neurosciences, the net margin of -39,662.8% is down versus -146.9% a few years ago.
Jupiter Neurosciences stock price
Jupiter Neurosciences business model & stock analysis
Frequently asked questions about Jupiter Neurosciences
7 analysts currently rate the Jupiter Neurosciences stock: 6 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Jupiter Neurosciences to generate revenue of 11.41 M USD and earnings per share of 4.50 USD.
Converted at the current exchange rate, the Jupiter Neurosciences share trades at 2.58 EUR (2.89 USD).
The expected revenue of Jupiter Neurosciences is 11.41 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Jupiter Neurosciences is 2.07 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Jupiter Neurosciences is currently 0.64. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Jupiter Neurosciences stock.
The price-to-sales ratio (P/S) of Jupiter Neurosciences is currently 0.12. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Jupiter Neurosciences stock.
The Eulerpool Quality Score for Jupiter Neurosciences is 2/10.
The ISIN of Jupiter Neurosciences is US48208B2034. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Jupiter Neurosciences is JUNS. The ticker symbol is used to trade Jupiter Neurosciences shares on the stock exchange.
Jupiter Neurosciences stock
Jupiter Neurosciences Peer Group
All fundamentals and in-depth analysis of Jupiter Neurosciences
Our stock analysis for Jupiter Neurosciences stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Jupiter Neurosciences. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.